The life sciences industry is leveraging AI to develop treatments for rare diseases that lack effective therapies.Axtria, a New Jersey-based company, is leading the charge in the AI-driven future of the industry.Axtria's GenAI Solutions, built on cloud platforms, enable scalability, predictive analysis, and personalized customer engagement.Axtria's AI-driven software, such as Axtria DataMAx, helps solve data integration and analytics challenges for life sciences organizations.